Canada’s February inflation rate expected to rise. - US data and Trump/Putin call in focus - USD dollar trading negatively ...
Technology investors are increasing their bullish bet on Intel (INTC). Team “Blue” hired a new CEO, Lip-Bu Tan. Although he ...
Angkor Resources Corp. (V.ANK) hit a new 52-week high of 28 cents Tuesday. Angko announces its Cambodian subsidiary, EnerCam ...
Momentum investors should appreciate the post-election rise in shares of Tesla (TSLA). After the President’s inauguration, ...
Canada's main stock index fell midday Tuesday as investors awaited the U.S. Federal Reserve's outlook on interest rate and economic growth amid the trade war. The TSX Composite Index was in the minus ...
Trump Media and Technology Group Corp. (NASDAQ: DJT), operator of the social media platform Truth Social, the streaming platform Truth+, and the FinTech brand Truth.Fi, announced that it filed its ...
Oil prices have fallen fast since the 3 March announcement from OPEC+ that it will go ahead with a planned rise in its collective oil production. The prospect of increased supply from the group has ...
The malaise continued to grip equity markets throughout North America Tuesday, with markets in Canada taking some blows, in suspense about what may happen with the U.S. Federal Reserve Wednesday. The ...
Inc to “Market Outperform” from “Market Perform,” citing upside potential from the company’s Max subscription model and a more attractive valuation after recent earnings and macro volatility.
The stock of Berkshire Hathaway (BRK.A/BRK.B) is outperforming the broader U.S. market this year, hitting a record high even as the benchmark S&P 500 index falls into a correction. Berkshire’s Class A ...
Mizuho initiated coverage of Bloom Energy Corp (NYSE:BE) with a “Neutral” rating and a price target of $28, saying that while the company benefits from increasing demand for power from data centers, ...
Co., Ltd. announced a definitive agreement to acquire Araris Biotech AG, a Swiss biotech company specializing in next-generation antibody drug conjugates (ADCs). The $400 million deal, ...